Permanent reversal of experimental diabetes in rats by allogeneic fetal pancreases across minor histocompatibility loci: effects and characteristics of immunosuppression induced by alloantigen, PCH, and ALS treatment.
D000818:Animals; D000961:Antilymphocyte Serum / Q000494:pharmacology; D003921:Diabetes Mellitus, Experimental / Q000628:therapy*; D005260:Female; D005333:Fetus / Q000033:anatomy & histology* / Q000276:immunology; D006085:Graft Survival / Q000187:drug effects; D006649:Histocompatibility Antigens / Q000276:immunology; D007166:Immunosuppressive Agents; D008297:Male; D016035:Pancreas Transplantation; D011344:Procarbazine / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains / Q000276:immunology
D000961:Antilymphocyte Serum; D006649:Histocompatibility Antigens; D007166:Immunosuppressive Agents; D011344:Procarbazine